Minerva Surgical to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Rhea-AI Summary

Minerva Surgical, Inc. (Nasdaq: UTRS), a women's health company specializing in solutions for Abnormal Uterine Bleeding (AUB), will present at the H.C. Wainwright 24th Annual Global Investment Conference. The presentation will be accessible on-demand starting 7:00 a.m. ET on September 12, 2022, for registered participants. Minerva focuses on minimally invasive alternatives to hysterectomy, aiming to address AUB and improve women's healthcare.

SANTA CLARA, Calif., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that its management will present at the H.C. Wainwright 24th Annual Global Investment Conference. The presentation will be available on-demand for registered participants through the H.C. Wainwright conference portal starting at 7:00 a.m. Eastern Time on Monday, September 12, 2022.

About Minerva Surgical, Inc.

Minerva Surgical is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. The Company has established a broad product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) in most uterine anatomies. The Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies.

MEDIA CONTACT

Mike Clapper
mike.clapper@minervasurgical.com
804-295-7676

INVESTOR RELATIONS CONTACT

Caroline Corner
investors@minervasurgical.com
415-202-5678

RELATED LINKS

https://www.aubandme.com

https://www.minervasurgical.com

FAQ

What is the purpose of Minerva Surgical's presentation at the H.C. Wainwright Conference?

Minerva Surgical's presentation aims to showcase their advancements in treating Abnormal Uterine Bleeding (AUB) and to engage with potential investors.

When can participants view Minerva Surgical's presentation?

Participants can access the on-demand presentation starting at 7:00 a.m. ET on September 12, 2022.

What is Minerva Surgical known for?

Minerva Surgical is known for developing minimally invasive solutions to treat Abnormal Uterine Bleeding (AUB) and to provide alternatives to hysterectomy.

What is the stock symbol for Minerva Surgical?

The stock symbol for Minerva Surgical is UTRS.

What healthcare needs does Minerva Surgical address?

Minerva Surgical addresses the distinct uterine healthcare needs of women, particularly focusing on Abnormal Uterine Bleeding (AUB) through innovative treatment options.